This inventor holds 1 USPTO granted patent. Top assignees: Fundación Cris De Investigación Para Vencer El Cáncer, Fundacion Para La Investigacion Biomedica Hospital 12 De Octubre, Hospital Clinic De Barcelona. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Belén Blanco Durango: Innovator in Bispecific Antibody Development
Introduction
Belén Blanco Durango is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of biomedicine, particularly in the development of bispecific antibodies. His work is aimed at advancing cancer treatment and improving patient outcomes.
Latest Patents
Belén holds a patent for an innovative invention titled "ANTI-CD19/ANTI-CD3 BISPECIFIC ANTIBODY, T CELLS SECRETING THE SAME, METHOD OF PREPARATION AND USE THEREOF." This patent represents a crucial step in the fight against cancer, showcasing his commitment to medical advancements. He has 1 patent to his name, reflecting his dedication to research and innovation.
Career Highlights
Throughout his career, Belén has worked with esteemed institutions such as Hospital Clinic de Barcelona and Fundación Cris de Investigación para Vencer el Cáncer. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Belén has collaborated with notable colleagues, including Luis Manuel Álvarez Vallina and Manel Juan Otero. These partnerships have enriched his work and fostered an environment of innovation and discovery.
Conclusion
Belén Blanco Durango is a pioneering inventor whose work in bispecific antibodies is making a significant impact in cancer research. His contributions to the field exemplify the importance of innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile